Provided by Tiger Fintech (Singapore) Pte. Ltd.

REMEGEN

104.400
+7.6507.91%
Volume:17.39M
Turnover:1.85B
Market Cap:58.84B
PE:-34.97
High:111.800
Open:98.250
Low:96.600
Close:96.750
52wk High:111.800
52wk Low:10.200
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:2.91
T/O Rate:8.34%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-2.986
ROE:-45.30%
ROA:-11.67%
PB:22.82
PE(LYR):-34.97
PS:25.95

Loading ...

Company Profile

Company Name:
REMEGEN
Exchange:
SEHK
Establishment Date:
2008
Employees:
3070
Office Location:
58 Middle Beijing Road,Yantai Development Zone,Yantai Area of Shandong Pilot Free Trade,Yantai,Shandong Province,China
Website:
- -
Zip Code:
- -
Fax:
86 53 5611 3517
Introduction:
RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The Company focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The Company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The Company mainly operates its businesses in the domestic and overseas markets.

Directors

Name
Position
WANG Wei Dong
Chairman of the Board,Executive Director,Member of the Strategic and Development Committee
LIN Jian
Executive Director,Member of the Remuneration and Assessment Committee
FANG JIANMIN
Executive Director,Core Technical Personnel,Chairman of the Strategic and Development Committee,Member of the Strategic and Development Committee
WEN Qing Kai
Executive Director,Member of the Strategic and Development Committee
HAO Xian Jing
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member,Audit Committee Chairman
CHEN Yun Jin
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Remuneration and Assessment Committee,Audit Committee Member
HUANG Guo Bin
Independent Director,Member of the Strategic and Development Committee,Chairman of the Nomination Committee,Member of the Nomination Committee
SU Xiao Di
Director,Member of the Strategic and Development Committee,Member of the Nomination Committee
WANG Li Qiang
Director,Member of the Strategic and Development Committee,Audit Committee Member
LIANG Wei
Securities Affairs Representative
FU Dao Tian
Core Technical Personnel

Shareholders

Name
Position
FANG JIANMIN
General Manager
TONG Shao Jing
CFO,Corporate Secretary
WEN Qing Kai
Board Secretary